PENTOLINIUM TARTRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pentolinium tartrate and what is the scope of patent protection?
Pentolinium tartrate
is the generic ingredient in one branded drug marketed by Wyeth Ayerst and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for PENTOLINIUM TARTRATE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 34 |
| Patent Applications: | 363 |
| DailyMed Link: | PENTOLINIUM TARTRATE at DailyMed |
Medical Subject Heading (MeSH) Categories for PENTOLINIUM TARTRATE
US Patents and Regulatory Information for PENTOLINIUM TARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ANSOLYSEN | pentolinium tartrate | INJECTABLE;INJECTION | 009372-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
